Charles Kinney's questions to Biostem Technologies Inc (BSEM) leadership • Q2 2024
Question
Charles Kinney asked about the company's initiatives for growth and diversification beyond its flagship product, AmnioWrap2.
Answer
Executive Jason Matuszewski outlined a multi-pronged strategy for diversification. This includes launching other product lines like VENDAJE and VENDAJE AC, targeting the hospital channel through GPO and IDN contracts, and expanding into federal channels like the VA and DoD. He also mentioned exploring other applications for perinatal tissue beyond wound care, such as in hospital surgical and burn settings.